These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3106122)

  • 1. Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect.
    Ostenson CG; Nylén A; Grill V; Gutniak M; Efendić S
    Diabetologia; 1986 Dec; 29(12):861-7. PubMed ID: 3106122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas.
    Efendić S; Grill V; Nylén A; Ostensson CG
    Diabetologia; 1982 Jun; 22(6):475-9. PubMed ID: 6125449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by IBMX, fasting and experimental diabetes of glibenclamide-induced islet hormone release from the perfused rat pancreas.
    Ostenson CG; Grill V; Nylén A; Efendić S
    Diabete Metab; 1983 Mar; 9(1):58-65. PubMed ID: 6189748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
    Ledercq-Meyer V; Akkan AG; Marchand J; Malaisse WJ
    Biochem Pharmacol; 1991 Sep; 42(8):1634-7. PubMed ID: 1930290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glibenclamide stimulates and glucose inhibits glucagon release induced by calcium deprivation.
    Grill V; Nylén A; Ostenson CG; Efendić S
    Diabetes; 1984 Jun; 33(6):505-9. PubMed ID: 6144608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas.
    Efendić S; Enzmann F; Nylén A; Uvnäs-Wallensten K; Luft R
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5901-4. PubMed ID: 118458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
    Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of alloxan- and streptozotocin-induced insulin deficiency on somatostatin and glucagon secretion by the perfused isolated rat pancreatico-duodenal preparation.
    Goto Y; Berelowitz M; Frohman LA
    Diabetologia; 1981; 20(1):66-71. PubMed ID: 6110604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.
    Grill V; Efendić S
    Diabetologia; 1983 Jan; 24(1):47-51. PubMed ID: 6131006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliclazide directly inhibits arginine-induced glucagon release.
    Cejvan K; Coy DH; Holst JJ; Cerasi E; Efendic S
    Diabetes; 2002 Dec; 51 Suppl 3():S381-4. PubMed ID: 12475779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of calcium in suppression of glucagon release from isolated diabetic rat pancreata.
    Fujita Y; Kawaji K; Moriya T; Matoba K; Ishii K; Yajima Y; Okabe H
    Tohoku J Exp Med; 1988 Feb; 154(2):185-93. PubMed ID: 3289140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide.
    Hirose H; Maruyama H; Seto Y; Ito K; Fujita T; Dan K; Kanda N; Saruta T; Kato R
    Pharmacology; 1995 Mar; 50(3):175-81. PubMed ID: 7746834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, glucagon and somatostatin in the perfused rat pancreas and the effects of HB 699 (4-(2-(5-chloro-2-metoxy-benzamido)-ethyl)-benzoic acid).
    Efendić S; Enzmann F; Gutniak M; Nylén A; Zoltobrocki M
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):573-9. PubMed ID: 6118003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas.
    Fujitani S; Ikenoue T; Akiyoshi M; Maki T; Yada T
    Metabolism; 1996 Feb; 45(2):184-9. PubMed ID: 8596487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling and sites of interaction for RX-871024 and sulfonylurea in the stimulation of insulin release.
    Efanov AM; Zaitsev SV; Efanova IB; Zhu S; Ostenson CG; Berggren PO; Efendić S
    Am J Physiol; 1998 Apr; 274(4):E751-7. PubMed ID: 9575838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphonylurea (glubenclamide) enhances somatostatin and inhibits glucagon release induced by arginine.
    Efendić S; Enzmann F; Nylén A; Uvnäs-Wallensten K; Luft R
    Acta Physiol Scand; 1980 Mar; 108(3):231-3. PubMed ID: 6103639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitters partially restore glucose sensitivity of insulin and glucagon secretion from perfused streptozotocin-induced diabetic rat pancreas.
    Ito K; Hirose H; Maruyama H; Fukamachi S; Tashiro Y; Saruta T
    Diabetologia; 1995 Nov; 38(11):1276-84. PubMed ID: 8582536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.